Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by PoorOpinionon Sep 14, 2018 12:50pm
104 Views
Post# 28621486

RE:RE:RE:RE:RE:IMV Inc. has 50 per cent upside, Mackie Research says

RE:RE:RE:RE:RE:IMV Inc. has 50 per cent upside, Mackie Research saysYikes, I dont think I could hold such a high percentage of my portfolio in one biotech. Forget the specifics of the IMV story, the average stats for failure in the industry are just too high. My strategy is a basket of biotech stocks and accepting a high failure rate just the way I play it. but hey the IMV story remains strong, you could all be big winners.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities